UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 182

Sortiert nach

Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1α expression, resulting in reduced angiogenesis

Oncogene, 2006-04, Vol.25 (17), p.2509-2519

2006

Link zum Volltext

Verfügbarkeit prüfen

681P OPTIM: A randomized phase II study on the OPTimization of IMmunotherapy in squamous carcinoma of the head and neck – AIO-KHT-0117

Annals of oncology, 2022-09, Vol.33, p.S854-S855

2022

Link zum Volltext

Verfügbarkeit prüfen

707TiP Postoperative adjuvant radiochemotherapy (aRCH) with cisplatin versus aRCH with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma: The ADRISK trial

Annals of oncology, 2022-09, Vol.33, p.S866

2022

Link zum Volltext

Verfügbarkeit prüfen

Folfoxiri + Bevacizumab (Bev) in Patients (Pts) with Previously Untreated Metastatic Colorectal Cancer (Mcrc): Final Survival and Pharmacogenomic Profiling Results from the Opal Study

Annals of oncology, 2014-09, Vol.25, p.iv176

2014

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of a phase II/III clinical study of the TLR9 agonist MGN1703 in patients with advanced colorectal carcinoma with disease control after first-line therapy: IMPACT study

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14114-e14114

2011

Link zum Volltext

Verfügbarkeit prüfen

Induction of Biphasic DNA Double Strand Breaks and Activation of Multiple Repair Protein Complexes by DNA Topoisomerase I Drug 7-Ethyl-10-hydroxy-camptothecin

Molecular pharmacology, 2002-04, Vol.61 (4), p.742-748

2002

Link zum Volltext

Verfügbarkeit prüfen

Chk1 signaling pathways that mediated G(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350

Biochemical and biophysical research communications, 2002-07, Vol.295 (2), p.435

2002

Link zum Volltext

Verfügbarkeit prüfen

Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiogenesis

Oncogene, 2006-04, Vol.25 (17), p.2509

2006

Link zum Volltext

Verfügbarkeit prüfen

Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1[alpha] expression, resulting in reduced angiogenesis

Oncogene, 2006-04, Vol.25 (17), p.2509

2006

Link zum Volltext

Verfügbarkeit prüfen

The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer

Oncogene, 2001-08, Vol.20 (38), p.5249-5257

2001

Link zum Volltext

Verfügbarkeit prüfen

519PFOLFOXIRI + BEVACIZUMAB (BEV) IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER (MCRC): FINAL SURVIVAL AND PHARMACOGENOMIC PROFILING RESULTS FROM THE OPAL STUDY

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv176-iv176

2014

Link zum Volltext

Verfügbarkeit prüfen

Chk1 signaling pathways that mediated G sub(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350

Biochemical and biophysical research communications, 2002-07, Vol.295 (2), p.435-444

2002

Link zum Volltext

Verfügbarkeit prüfen

Targeting molecular signals in chk1 pathways as a new approach for overcoming drug resistance

Cancer and metastasis reviews, 2001-01, Vol.20 (1-2), p.109-115

2001

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38

International journal of oncology, 2002-11, Vol.21 (5), p.1059

2002

Link zum Volltext

Verfügbarkeit prüfen

Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines

Cancer chemotherapy and pharmacology, 1993, Vol.33 (1), p.43-47

1993

Link zum Volltext

Verfügbarkeit prüfen

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

Nature medicine, 2011-05, Vol.17 (5), p.581-588

2011

Link zum Volltext

Verfügbarkeit prüfen

Geomorphic and human influence on large-scale coastal change

Geomorphology (Amsterdam), 2013-10, Vol.199, p.160-170

2013

Link zum Volltext

Verfügbarkeit prüfen

Decoupling processes and scales of shoreline morphodynamics

Marine geology, 2016-11, Vol.381, p.42-53

2016

Link zum Volltext

Verfügbarkeit prüfen

On Acceleration of SAT-Based ATPG for Industrial Designs

IEEE transactions on computer-aided design of integrated circuits and systems, 2008-07, Vol.27 (7), p.1329-1333

2008

Link zum Volltext
IEEE_Xplore

12-year changes in cardiovascular risk factors in people with major depressive or bipolar disorder: a prospective cohort analysis in Germany

European archives of psychiatry and clinical neuroscience, 2019-08, Vol.269 (5), p.565-576

2019

Link zum Volltext

Verfügbarkeit prüfen

Concept, Design and Manufacture of a Prototype Hydrogen Storage Tank Based on Sodium Alanate

Chemical engineering & technology, 2009-08, Vol.32 (8), p.1154-1163

2009

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Experimental investigation of exergy losses of a PEM fuel cell system

Forschung im Ingenieurwesen, 2020-12, Vol.84 (4), p.387-387

2020

Link zum Volltext

Verfügbarkeit prüfen

Bipolare Störungen: Das Praxishandbuch

2nd ed., 2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(157)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(167)
Japanisch
(20)
Deutsch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1α expression, resulting in reduced angiogenesis

681P OPTIM: A randomized phase II study on the OPTimization of IMmunotherapy in squamous carcinoma of the head and neck – AIO-KHT-0117

1535P Paclitaxel + ramucirumab versus paclitaxel alone in patients with squamous-cell carcinoma of the oesophagus, refractory or intolerant to combination therapy with fluoropyrimidine and platinum-based drugs: Final results from the randomized phase II IKF-S627/RAMOS trial of the AIO

707TiP Postoperative adjuvant radiochemotherapy (aRCH) with cisplatin versus aRCH with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma: The ADRISK trial

Folfoxiri + Bevacizumab (Bev) in Patients (Pts) with Previously Untreated Metastatic Colorectal Cancer (Mcrc): Final Survival and Pharmacogenomic Profiling Results from the Opal Study

Preliminary results of a phase II/III clinical study of the TLR9 agonist MGN1703 in patients with advanced colorectal carcinoma with disease control after first-line therapy: IMPACT study

Induction of Biphasic DNA Double Strand Breaks and Activation of Multiple Repair Protein Complexes by DNA Topoisomerase I Drug 7-Ethyl-10-hydroxy-camptothecin

Chk1 signaling pathways that mediated G(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350

Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiogenesis

Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1[alpha] expression, resulting in reduced angiogenesis

The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer

519PFOLFOXIRI + BEVACIZUMAB (BEV) IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER (MCRC): FINAL SURVIVAL AND PHARMACOGENOMIC PROFILING RESULTS FROM THE OPAL STUDY

Chk1 signaling pathways that mediated G sub(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350

Targeting molecular signals in chk1 pathways as a new approach for overcoming drug resistance

Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38

Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

Geomorphic and human influence on large-scale coastal change

Decoupling processes and scales of shoreline morphodynamics

On Acceleration of SAT-Based ATPG for Industrial Designs

12-year changes in cardiovascular risk factors in people with major depressive or bipolar disorder: a prospective cohort analysis in Germany

Concept, Design and Manufacture of a Prototype Hydrogen Storage Tank Based on Sodium Alanate

Erratum to: Experimental investigation of exergy losses of a PEM fuel cell system

Bipolare Störungen: Das Praxishandbuch

Suchergebnisse filtern